Latest News about CPRX
Recent news which mentions CPRX
7 A-Rated Stocks to Buy for April 2023
April 07, 2023
From InvestorPlace
2 Top Growth Stocks That Can Withstand an Economic Downturn
April 05, 2023
From Motley Fool
Analyst Expectations for Catalyst Pharmaceuticals's Future
March 20, 2023
Tickers
CPRX
From Benzinga
4 Analysts Have This to Say About Catalyst Pharmaceuticals
March 20, 2023
Tickers
CPRX
From Benzinga
Earnings Scheduled For March 15, 2023
March 15, 2023
From Benzinga
7 Core Stocks to Build a Solid Portfolio Around
March 13, 2023
From InvestorPlace
2 Growth Stocks to Invest $1,000 in Right Now
March 03, 2023
From Motley Fool
2 Breakout Growth Stocks to Buy for the Long Haul
March 03, 2023
From Motley Fool
7 Smart Stock Picks for Cautious Investors
February 28, 2023
From InvestorPlace
The 7 Best Growth Stocks to Buy for February 2023
February 06, 2023
Tags
ACLS
ESALF
NASDAQ:CPRX,OTCMKTS:ESALF,NYSE:TEVA,NASDAQ:ACLS,NYSE:NOW,NYSE:DAR,NASDAQ:ICLR,NYSE:PFGC,NASDAQ:LSCC
From InvestorPlace
Down 30% in a Day, Is Catalyst Pharmaceuticals Doomed?
January 26, 2023
From Motley Fool
Here's How Much $1000 Invested In Catalyst Pharmaceuticals 15 Years Ago Would Be Worth Today
January 25, 2023
Tickers
CPRX
From Benzinga
Nasdaq Rises 1.5%; Pliant Therapeutics Shares Spike Higher
January 23, 2023
From Benzinga
Why Evoqua Water Technologies Shares Are Trading Higher By 10%? Here Are Other Stocks Moving In Monday's Mid-Day Session
January 23, 2023
From Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
January 23, 2023
From Benzinga
Dow Jumps Over 300 Points; Crude Oil Up 1%
January 23, 2023
From Benzinga
From Benzinga
Catalyst Pharma Shares Take A Hit As Teva Files For Generic Version Of Its Lead Product
January 23, 2023
From Benzinga
US Stocks Mostly Higher; Synchrony Financial Earnings Top Views
January 23, 2023
From Benzinga
Analyst Expectations for Catalyst Pharmaceuticals's Future
January 19, 2023
Tickers
CPRX
From Benzinga
HC Wainwright & Co. Maintains Buy Rating for Catalyst Pharmaceuticals: Here's What You Need To Know
December 21, 2022
Tickers
CPRX
From Benzinga
Catalyst Pharma Acquires US Rights To Eisai's Epilepsy Drug
December 20, 2022
From Benzinga